نموذج المقصورة الواحدة: التسريب الوريدي

IV infusion is preferred when maintaining constant and stable drug concentration is critical, such as with antibiotics where dosage control is essential. It is also used when drugs pose toxicity risks, allowing precise control and immediate drug action while bypassing first-pass metabolism.

At steady-state or infusion equilibrium, the rate of drug infusion equals the elimination rate, resulting in constant drug concentration in the body. This balanced state occurs when drug input and output are equal, preventing further drug accumulation despite continued infusion administration.

The elimination rate constant, a crucial pharmacokinetic parameter, is determined from a semilog plasma concentration-time plot by calculating the slope of the line. This value is essential for understanding drug removal kinetics and predicting how plasma concentration changes over time during and after infusion.

Apparent volume of distribution and total systemic clearance can be estimated using steady-state concentration and infusion rate. These critical metrics can also be computed from the total area under the curve until the end of infusion, enabling accurate dosage regimen design.

A loading dose is administered when rapid therapeutic concentration is needed, allowing the drug to reach effective levels quickly. The combined impact of both the loading dose and infusion can be calculated using specific mathematical equations to achieve desired plasma concentrations.

In the one-compartment model, the rate of change in drug amount equals the difference between infusion and elimination rates. These mathematical equations form the foundation for predicting drug behavior and are essential for understanding how infusion rate and elimination kinetics determine plasma concentration profiles.

The elimination rate constant, k, directly determines half-life and clearance, which are derived pharmacokinetic parameters essential for dosage design. These calculations from k are crucial for predicting how long therapeutic concentrations persist after infusion stops and ensuring safe and effective drug therapy.